Multiple Sclerosis in Children: Current and Emerging Concepts

Overview

Journal Semin Neurol

Specialty Neurology

Date 2020 Apr 16

PMID 32294785

Citations 10

Authors

J Nicholas Brenton

Ryan Kammeyer

Lauren Gluck

Teri Schreiner

Naila Makhani

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis is being increasingly recognized and diagnosed in children. In the past several years, advances have been made in diagnosing multiple sclerosis in children, identifying new genetic and environmental risk factors, delineating underlying immunobiology, characterizing imaging findings, and implementing new treatment strategies. In this review, we discuss these advances. Future research into the determinants of multiple sclerosis in children and into new treatment options will be aided by continued international collaboration.

Citing Articles

Respiratory functions, respiratory muscle strength and fatigue in patients with pediatric-onset multiple sclerosis: a comparative cross-sectional study.

Vural P, Akinci B, Guler S, Saltik S, Yazgan Y Acta Neurol Belg. 2024; 125(1):69-75.

PMID: 39168946 DOI: 10.1007/s13760-024-02628-4.

Changes of Target Essential Trace Elements in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Stojsavljevic A, Jagodic J, Perovic T, Manojlovic D, Pavlovic S Biomedicines. 2024; 12(7).

PMID: 39062163 PMC: 11274787. DOI: 10.3390/biomedicines12071589.

Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study.

De Masi R, Orlando S, Carata E, Panzarini E Int J Mol Sci. 2024; 25(13).

PMID: 38999977 PMC: 11241448. DOI: 10.3390/ijms25136867.

Pediatric traumatic brain injury and early age multiple sclerosis in Finland: A nationwide register-based cohort study.

Laaksonen J, Ponkilainen V, Kuitunen I, Mottonen J, Mattila V Brain Behav. 2024; 14(4):e3478.

PMID: 38622897 PMC: 11019240. DOI: 10.1002/brb3.3478.

Multiple sclerosis under the age of ten: the challenge of a rare diagnosis in a special population - a case series.

Carvalho I, Dos Santos C, Amaral J, Ribeiro J, Pereira C, Pais R Front Neurosci. 2024; 17:1297171.

PMID: 38174051 PMC: 10761493. DOI: 10.3389/fnins.2023.1297171.

References

Bizjak N, Osredkar D, Perkovic Benedik M, Sega Jazbec S . Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: A descriptive nation-wide study. Mult Scler Relat Disord. 2017; 18:56-59. DOI: 10.1016/j.msard.2017.09.017. View

Hennes E, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A . Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017; 89(9):900-908. DOI: 10.1212/WNL.0000000000004312. View

Mikaeloff Y, Caridade G, Tardieu M, Suissa S . Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain. 2007; 130(Pt 10):2589-95. DOI: 10.1093/brain/awm198. View

Banwell B, Bar-Or A, Arnold D, Sadovnick D, Narayanan S, McGowan M . Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011; 10(5):436-45. DOI: 10.1016/S1474-4422(11)70045-X. View

Grover S, Aubert-Broche B, Fetco D, Collins D, Arnold D, Finlayson M . Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis. Neurology. 2015; 85(19):1663-9. PMC: 4653106. DOI: 10.1212/WNL.0000000000001939. View

Gianfrancesco M, Stridh P, Rhead B, Shao X, Xu E, Graves J . Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017; 88(17):1623-1629. PMC: 5405763. DOI: 10.1212/WNL.0000000000003849. View

Makhani N, Schreiner T . Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study. Pediatr Neurol. 2016; 57:101-4. DOI: 10.1016/j.pediatrneurol.2016.01.010. View

Lavery A, Collins B, Waldman A, Hart C, Bar-Or A, Marrie R . The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk. Mult Scler. 2018; 25(4):515-522. DOI: 10.1177/1352458518757089. View

Kornek B, Aboul-Enein F, Rostasy K, Milos R, Steiner I, Penzien J . Natalizumab therapy for highly active pediatric multiple sclerosis. JAMA Neurol. 2013; 70(4):469-75. DOI: 10.1001/jamaneurol.2013.923. View

10.

Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J . Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol. 2018; 5(10):1222-1228. PMC: 6186938. DOI: 10.1002/acn3.636. View

11.

Rocca M, de Meo E, Amato M, Copetti M, Moiola L, Ghezzi A . Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions. Mult Scler. 2014; 21(7):956-9. DOI: 10.1177/1352458514557303. View

12.

Ghezzi A, Moiola L, Pozzilli C, Brescia-Morra V, Gallo P, Grimaldi L . Natalizumab in the pediatric MS population: results of the Italian registry. BMC Neurol. 2015; 15:174. PMC: 4583752. DOI: 10.1186/s12883-015-0433-y. View

13.

Yea C, Tellier R, Chong P, Westmacott G, Marrie R, Bar-Or A . Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology. 2013; 81(16):1392-9. PMC: 3806908. DOI: 10.1212/WNL.0b013e3182a841e4. View

14.

Maranzano J, Till C, Assemlal H, Fonov V, Brown R, Araujo D . Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI. Mult Scler. 2018; 25(7):980-986. DOI: 10.1177/1352458518779952. View

15.

Torkildsen O, Myhr K, Bo L . Disease-modifying treatments for multiple sclerosis - a review of approved medications. Eur J Neurol. 2015; 23 Suppl 1:18-27. PMC: 4670697. DOI: 10.1111/ene.12883. View

16.

Makhani N, Gorman M, Branson H, Stazzone L, Banwell B, Chitnis T . Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology. 2009; 72(24):2076-82. PMC: 2923592. DOI: 10.1212/WNL.0b013e3181a8164c. View

17.

Ahn J, OMahony J, Moshkova M, Hanwell H, Singh H, Zhang M . Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice. Mult Scler. 2014; 21(6):735-48. DOI: 10.1177/1352458514551453. View

18.

Ghassemi R, Narayanan S, Banwell B, Sled J, Shroff M, Arnold D . Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PLoS One. 2014; 9(2):e85741. PMC: 3935826. DOI: 10.1371/journal.pone.0085741. View

19.

de Mol C, Wong Y, van Pelt E, Ketelslegers I, Bakker D, Boon M . Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study. J Neurol. 2018; 265(6):1310-1319. PMC: 5990581. DOI: 10.1007/s00415-018-8835-6. View

20.

Datta R, Sethi V, Ly S, Waldman A, Narula S, Dewey B . 7T MRI Visualization of Cortical Lesions in Adolescents and Young Adults with Pediatric-Onset Multiple Sclerosis. J Neuroimaging. 2017; 27(5):447-452. PMC: 5581206. DOI: 10.1111/jon.12465. View